FDA Inspection 1237492 — Shandong Xinhua Pharmaceutical Company Limited Hutian Branch
The FDA completed an inspection of Shandong Xinhua Pharmaceutical Company Limited Hutian Branch on April 5, 2024 in Zibo. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zibo (China)